Search

everythinglearnresearchcommunity

for

Search:↓

Both treatments reduced androgen levels and hair growth in women with hirsutism.

Oestrogen does not affect adrenal androgen levels in children and adolescents.

Certain ESR1 gene variations may affect hormone levels and fat distribution in women with high male hormone levels.

Women with PCOS have higher PSA levels, which are linked to increased male hormone levels and hirsutism.

A dissolving microneedle patch with collagen XVII effectively promotes hair regrowth in androgenic alopecia.

Transdermal exposure to certain steroids can be detected in urine for up to 14 days.

Higher DHEA-S levels are linked to smaller ovarian volume in women with PCOS.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

CYP154C7 enzyme can effectively modify steroids and is promising for commercial use.

The method can measure multiple hormones in women's hair and may help identify hormone-related health issues.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

Human hair follicles can process steroid hormones like DHEA.

Intramuscular cyproterone acetate effectively treats hirsutism and improves skin conditions in women with hyperandrogenism.

A 5 mg dose of transdermal testosterone cream effectively restores testosterone levels in postmenopausal women.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

Masculinization in affected individuals occurs gradually after puberty due to hormone changes.

PM-9 and finasteride effectively inhibit the enzyme that converts testosterone to DHT.

Mutations in the CYP21A2 gene are not a major factor in causing PCOS.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

Prenatally androgenized ewes can model increased hair diameter in women with PCOS.

Researchers had trouble finding enough participants for a trial on DHEA's effects on postmenopausal women's sexual desire.

Epitestosterone may counteract testosterone's effects and has roles in body processes like prostate growth and hair distribution.

Topical DHEA safely increases skin oil production.

A reliable method was developed to measure perospirone levels in human plasma for clinical use.

Androgen measurements are mostly unnecessary for diagnosing PCOS, except in women with menstrual issues.

PRO-C22 can help diagnose and monitor the severity of hidradenitis suppurativa.